Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RCUS
#1698
Arcus Biosciences, Inc.
23.1
3
USD
+0.87%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+0.87%
Mudança mensal
+2.57%
Mudança em 6 meses
+36.22%
Mudança anual
+195.78%
Fechamento anterior
22.9
3
Abrir
23.1
3
Bid
Ask
Mínimo
23.1
3
High
23.1
3
Volume
1
Mercados
Ações
Cuidados de saúde
RCUS
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
70.88 M
71.06 M
73.01 M
90.86 M
105.84 M
125.35 M
—
Valuation ratios
Enterprise value
1.67 B
2.73 B
1.27 B
1.66 B
1.58 B
2.96 B
5.73 B
Price to earnings ratio
-11.58
57
-5.44
-4.74
-4.74
-7.24
-15.54
Price to sales ratio
18.35
7.82
12.99
12.45
5.2
10.36
24.5
Price to cash flow ratio
12.79
-11.69
3.32
-4.76
-7.89
-5.31
-13.1
Price to book ratio
2.83
3.56
2.21
3.15
2.77
4.06
5.43
Enterprise value to EBITDA ratio
-13.41
46.22
—
-4.63
-4.46
-7.43
-14.42
Profitability ratios
Return on assets %
-0.16
0.03
-0.2
-0.28
-0.25
-0.31
-0.33
Return on equity %
-0.24
0.06
-0.41
-0.66
-0.58
-0.56
-0.69
Return on invested capital %
-102.44
25.71
-151.5
-333.84
-370.54
-517.25
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-160.27
14.17
-250
-290.6
-127.91
-156.28
-1 332.32
EBITDA margin %
-160.33
15.41
—
-306.84
-137.6
-161.54
-1 369.11
Net margin %
-158.49
13.8
-238.39
-262.39
-109.69
-142.91
-1 240.44
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.05
7.6
5.53
4.52
4.5
4.36
17.88
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.16
0.32
0.08
0.1
0.23
0.22
0.22
Solvency ratios
Debt to assets ratio
—
—
—
—
0.14
0.17
0.44
Debt to equity ratio
—
—
—
—
0.33
0.31
0.88
Long term debt to total assets ratio
—
—
—
—
0.04
0.09
0.32
Long term debt to total equity ratio
—
—
—
—
0.1
0.16
0.65
Per share metrics
Operating cash flow per share
2.03
-3.46
6.08
-4.14
-1.89
-4.49
-4.62
EBIT per share
-2.27
0.73
-3.89
-4.59
-3.66
-3.59
-3.71
EBITDA per share
-2.27
0.8
—
-4.85
-3.94
-3.72
-3.83
Total debt per share
—
—
—
—
1.76
1.84
4.52
Cash per share
3.17
6.75
14.01
10.26
10.85
9.13
35.62
Net current asset value per share
13.43
17.06
14.82
11.23
11.28
9.38
36.78
Tangible book value per share
9.17
11.38
9.13
6.24
5.38
5.88
20.52
Working capital per share
11.21
14.81
12.14
8.74
8.77
7.23
28.5
Book value per share
9.17
11.38
9.13
6.24
5.38
5.88
20.52
Notícias
Diretora de operações da Arcus Biosciences renuncia em 30 de março
Arcus Biosciences na conferência Leerink: dados promissores do casdatifan
Arcus Biosciences at Leerink Conference: Casdatifan’s Promising Data
Arcus Biosciences: Q4 Beat And Casdatifan’s Story So Far (NYSE:RCUS)
Palantir, United Tech among market cap stock movers on Monday
Palantir and AeroVironment among market cap stock movers on Monday
Arcus Biosciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NYSE:RCUS) 2026-02-27
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline
Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues